ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,377,517 | -25.7% | 51,266 | -1.4% | 1.78% | -20.4% |
Q2 2023 | $1,854,677 | +40.8% | 52,010 | +0.3% | 2.23% | +22.3% |
Q1 2023 | $1,317,701 | -64.7% | 51,878 | -43.7% | 1.83% | -49.1% |
Q4 2022 | $3,735,373 | +46.7% | 92,095 | +19.5% | 3.59% | +46.4% |
Q3 2022 | $2,546,000 | +10.8% | 77,049 | +18.1% | 2.45% | -2.1% |
Q2 2022 | $2,297,000 | -43.7% | 65,239 | -26.5% | 2.50% | -11.8% |
Q1 2022 | $4,082,000 | -46.7% | 88,749 | -23.2% | 2.84% | -22.9% |
Q4 2021 | $7,663,000 | +16.4% | 115,580 | +9.6% | 3.68% | +25.9% |
Q3 2021 | $6,586,000 | +2.2% | 105,491 | +35.6% | 2.92% | -1.6% |
Q2 2021 | $6,445,000 | +33.2% | 77,815 | +6.7% | 2.97% | +3.9% |
Q1 2021 | $4,837,000 | +30.6% | 72,948 | +51.1% | 2.86% | +1.3% |
Q4 2020 | $3,703,000 | – | 48,265 | – | 2.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |